Abby and Patrick continue their series on psychedelics via an in-depth interview with Dr. Dan Karlin. Karlin is a psychiatrist and Chief Medical Officer at MindMed, where he oversees clinical trials using LSD to treat major depressive disorder (MDD) and generalized anxiety disorder (GAD). Karlin first fills Abby and Patrick in about those disorders, MindMed’s ongoing clinical trials, and both the history of LSD research and potential near-future therapeutic applications. In the wide-ranging c...
All content for Ordinary Unhappiness is the property of Patrick & Abby and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Abby and Patrick continue their series on psychedelics via an in-depth interview with Dr. Dan Karlin. Karlin is a psychiatrist and Chief Medical Officer at MindMed, where he oversees clinical trials using LSD to treat major depressive disorder (MDD) and generalized anxiety disorder (GAD). Karlin first fills Abby and Patrick in about those disorders, MindMed’s ongoing clinical trials, and both the history of LSD research and potential near-future therapeutic applications. In the wide-ranging c...
Subscribe to get access to the full episode, the episode reading list, and all premium episodes! www.patreon.com/OrdinaryUnhappiness Abby and Dan process Coralie Fargeat’s The Substance (2024), starring Demi Moore and Margaret Qualley. From uncanny doubles to unsparing mirrors to the punishing reality principle of getting older, it’s a film that offers plenty of grist for the psychoanalytic mill. It’s also an occasion for Abby and Dan to reflect on sexual difference, gendered expectations, th...
Ordinary Unhappiness
Abby and Patrick continue their series on psychedelics via an in-depth interview with Dr. Dan Karlin. Karlin is a psychiatrist and Chief Medical Officer at MindMed, where he oversees clinical trials using LSD to treat major depressive disorder (MDD) and generalized anxiety disorder (GAD). Karlin first fills Abby and Patrick in about those disorders, MindMed’s ongoing clinical trials, and both the history of LSD research and potential near-future therapeutic applications. In the wide-ranging c...
